Kim L. Habets

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice.

CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice.

Journal: PloS one

Published: June 28, 2017

The production and secretion of complement component C1q by human mast cells.

The production and secretion of complement component C1q by human mast cells.

Journal: Molecular immunology

Published: June 13, 2016

Leukocyte Bim deficiency does not impact atherogenesis in ldlr -/- mice, despite a pronounced induction of autoimmune inflammation.

Leukocyte Bim deficiency does not impact atherogenesis in ldlr -/- mice, despite a pronounced induction of autoimmune inflammation.

Journal: Scientific reports

Published: June 08, 2016

Expansion of Th17 Cells by Human Mast Cells Is Driven by Inflammasome-Independent IL-1β.

Expansion of Th17 Cells by Human Mast Cells Is Driven by Inflammasome-Independent IL-1β.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 21, 2015

Abatacept decreases disease activity in a absence of CD4(+) T cells in a collagen-induced arthritis model.

Abatacept decreases disease activity in a absence of CD4(+) T cells in a collagen-induced arthritis model.

Journal: Arthritis research & therapy

Published: April 28, 2015

Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue.

Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue.

Journal: The Journal of allergy and clinical immunology

Published: April 11, 2015

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: December 16, 2014

Ability of Interleukin-33- and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune Responses.

Ability of Interleukin-33- and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune Responses.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 13, 2014

Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.

Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 03, 2014

Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis.

Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: September 27, 2013

Platelets and autoimmunity.

Platelets and autoimmunity.

Journal: European journal of clinical investigation

Published: February 01, 2013

Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration.

Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 26, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026